A five-m6A regulatory gene signature is a prognostic biomarker in lung adenocarcinoma patients

Xiao Wu, Hongxu Sheng, Luming Wang, Pinghui Xia, Yiqing Wang, Yu Li, Wang Lv, Jian Hu

Aging · 2021 · 18 citations · 75 references

DOIFull text

Open access

Concepts

Abstract

T cells in the tumor tissues and improved response to immune checkpoint blockade therapy. These findings show that this five-m6A regulatory gene signature is a prognostic biomarker in LADC and that immune checkpoint blockade is a potential therapeutic option for high-risk LADC patients.

References

75